Predictors of response and remission in a naturalistic inpatient sample undergoing multimodal treatment for depression

被引:11
作者
Chae, Woo Ri [1 ,2 ,3 ,4 ]
Nagel, Johanna M. [1 ,2 ,3 ,4 ]
Kuehl, Linn K. [1 ,2 ,3 ,4 ]
Gold, Stefan M. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Wingenfeld, Katja [1 ,2 ,3 ,4 ]
Otte, Christian [1 ,2 ,3 ,4 ]
机构
[1] Charite Univ Med Berlin, Campus Benjamin Franklin,Hindenburgdamm 30, D-12203 Berlin, Germany
[2] Free Univ Berlin, Campus Benjamin Franklin,Hindenburgdamm 30, D-12203 Berlin, Germany
[3] Humboldt Univ, Campus Benjamin Franklin,Hindenburgdamm 30, D-12203 Berlin, Germany
[4] Berlin Inst Hlth, Klin Psychiat & Psychotherapie, Campus Benjamin Franklin,Hindenburgdamm 30, D-12203 Berlin, Germany
[5] Charite Univ Med Berlin, Campus Benjamin Franklin, Berlin, Germany
[6] Free Univ Berlin, Campus Benjamin Franklin, Berlin, Germany
[7] Humboldt Univ, Campus Benjamin Franklin, Berlin, Germany
[8] Berlin Inst Hlth, Med Klin mS Psychosomat, Campus Benjamin Franklin, Berlin, Germany
[9] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, Inst Neuroimmunol & Multiple Sklerose INIMS, Hamburg, Germany
关键词
Depression; Treatment; Predictor; Response; Remission; Chronicity; STAR-ASTERISK-D; CLINICAL PREDICTORS; EARLY IMPROVEMENT; MAJOR DEPRESSION; ANTIDEPRESSANT TREATMENT; FOLLOW-UP; DISORDER; 1ST; METAANALYSIS; CHRONICITY;
D O I
10.1016/j.jad.2019.04.044
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Many depressed patients do not achieve response or remission despite adequate treatment. Identifying predictors of outcome can contribute to developing therapeutic algorithms for difficult-to-treat depression. Therefore, we examined clinical predictors of response and remission in a naturalistic inpatient sample undergoing multimodal treatment for depression. Methods: Three hundred and fifty-one consecutive inpatients admitted to a tertiary care university hospital (specialized psychiatry unit for treatment of unipolar and bipolar depression) between January 2014 and December 2016 were characterized by a set of sociodemographic and clinical variables. The predictive value of these variables for response >= 50% decrease from baseline Montgomery-Asberg Depression Rating Scale (MADRS) score) and remission (MADRS score at discharge < 10) were explored using bivariate analysis and logistic regression. Results: Greater symptom severity and fewer psychotropic medications at the time of admission predicted response. Remission rates were higher for patients with non-chronic depression, higher number of previous depressive episodes, fewer psychotropic medications and less severe depression at admission. Limitations: This was a retrospective study without a control group. The sample was drawn from a single inpatient ward specialized for difficult-to-treat depression. Conclusions: Greater baseline depression severity might be a proxy for a less chronic course of depression thereby explaining its association with greater response rates. Fewer episodes in the past and polypharmacy could indicate treatment-resistance and chronicity, contributing to lower remission rates. Therefore, preventing chronicity should be a central aim of depression treatment.
引用
收藏
页码:99 / 106
页数:8
相关论文
共 39 条
  • [31] Clinical factors associated with treatment resistance in major depressive disorder: Results from a European multicenter study
    Souery, Daniel
    Oswald, Pierre
    Massat, Isabelle
    Bailer, Ursula
    Bollen, Joseph
    Demyttenaere, Koen
    Kasper, Siegfried
    Lecrubier, Yves
    Montgomery, Stuart
    Serretti, Alessandro
    Zohar, Joseph
    Mendlewicz, Julien
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (07) : 1062 - 1070
  • [32] Early Improvement in the First 2 Weeks as a Predictor of Treatment Outcome in Patients With Major Depressive Disorder: A Meta-Analysis Including 6562 Patients
    Szegedi, Armin
    Jansen, Wim T.
    van Willigenburg, Arjen P. P.
    van der Meulen, Egbert
    Stassen, Hans H.
    Thase, Michael E.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (03) : 344 - 353
  • [33] Duration of major and minor depressive episodes and associated risk indicators in a psychiatric epidemiological cohort study of the general population
    ten Have, M.
    Penninx, B. W. J. H.
    Tuithof, M.
    van Dorsselaer, S.
    Kleinjan, M.
    Spijker, J.
    de Graaf, R.
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 2017, 136 (03) : 300 - 312
  • [34] Thase ME, 1997, J CLIN PSYCHIAT, V58, P23
  • [35] Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice
    Trivedi, MH
    Rush, AJ
    Wisniewski, SR
    Nierenberg, AA
    Warden, D
    Ritz, L
    Norquist, G
    Howland, RH
    Lebowitz, B
    McGrath, PJ
    Shores-Wilson, K
    Biggs, MM
    Balasubramani, GK
    Fava, M
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2006, 163 (01) : 28 - 40
  • [36] Predictors of treatment outcome in depression in later life: A systematic review and meta-analysis
    Tunvirachaisakul, Chavit
    Gould, Rebecca L.
    Coulson, Mark C.
    Ward, Emma V.
    Reynolds, Gemma
    Gathercole, Rebecca L.
    Grocott, Hannah
    Supasitthumrong, Thitiporn
    Tunvirachaisakul, Athicha
    Kimona, Kate
    Howard, Robert J.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2018, 227 : 164 - 182
  • [37] An Inflammatory Biomarker as a Differential Predictor of Outcome of Depression Treatment With Escitalopram and Nortriptyline
    Uher, Rudolf
    Tansey, Katherine E.
    Dew, Tracy
    Maier, Wolfgang
    Mors, Ole
    Hauser, Joanna
    Dernovsek, Mojca Zvezdana
    Henigsberg, Neven
    Souery, Daniel
    Farmer, Anne
    McGuffin, Peter
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2014, 171 (12) : 1278 - 1286
  • [38] Early improvement as a resilience signal predicting later remission to antidepressant treatment in patients with Major Depressive Disorder: Systematic review and meta-analysis
    Wagner, Stefanie
    Engel, Alice
    Engelmann, Jan
    Herzog, David
    Dreimueller, Nadine
    Mueller, Marianne B.
    Tadic, Andre
    Lieb, Klaus
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2017, 94 : 96 - 106
  • [39] Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?
    Zimmerman, M
    Mattia, JI
    Posternak, MA
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (03) : 469 - 473